Cannabis firms ready FDA ingredient notifications with eye on legalization
Cannabis manufacturers with national ambitions for when the United States legalizes marijuana and CBD are plowing big money…
News May 13
Latest In: cbd
No hallucination: Psychedelics could be next cannabis-like boom
Investors as well as cannabis companies and executives are rushing into psychedelics, a multibillion-dollar opportunity that reminds some…
News May 3
Minor cannabinoids will likely have a large role in the wellness industry
Move over CBD. Make way for CBN and CBG. Hemp and marijuana executives say the booming wellness market…
News May 1
Experts point to breeding and extraction as ways to capture minor cannabinoids
As minor cannabinoids gain popularity and acceptance among cannabis consumers, extraction companies looking to cash in on the…
News May 1
Lygos CBx scales up bio-based production of cannabinoids
A San Francisco Bay Area company that specializes in low-cost alternatives to plant-derived cannabinoids has launched commercial-scale production.…
News April 5
Largest human CBD trial launches with eye toward checking safety of trace THC
The largest-yet human CBD toxicological trial has been launched in Europe to check the effects of consuming trace…
News March 19
Unique cannabinoid delta-8 divides cannabis extraction industry
A rare cannabinoid that mimics the effects of delta-9 THC but can easily be produced from CBD is…
News March 16
FTC cracks down on deceptive CBD health claims
On December 17, the Federal Trade Commission (FTC) announced its first crackdown on deceptive marketing claims for CBD…
News January 18
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement
Canadian cannabis producer Canopy Growth Corp. is suing Britain's GW Pharmaceuticals in U.S. federal court, alleging that GW…
News December 23Featured
1
Latest Sponsored
